Toll-like receptors;Toll-like récepteurs

Pathologie Biologie

Volumn 57, Issue 5, 2009, Pages 430-438

  Essakalli, M ^a,b   Atouf, O ^a   Bennani, N ^a   Benseffaj, N ^a   Ouadghiri, S ^a   Brick, C ^a  

^a IBN SINA HOSPITAL   (Morocco)

^b MOHAMMED V UNIVERSITY   (Morocco)

Author keywords

Adaptive immunity; Innate immunity; Signaling pathways; Therapeutic prospects; TLR

Indexed keywords

TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR AGONIST; VACCINE;

ADAPTIVE IMMUNITY; ALLERGY; AUTOIMMUNE DISEASE; CELL ACTIVATION; CHRONIC INFLAMMATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; IMMUNOSTIMULATION; INFLAMMATORY CELL; INNATE IMMUNITY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; ANIMALS; ANTI-ALLERGIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; DRUG DELIVERY SYSTEMS; GRAFT REJECTION; HUMANS; HYPERSENSITIVITY; INFECTION; LIGANDS; LYMPHOCYTE SUBSETS; NEOPLASMS; NF-KAPPA B; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; VACCINES;

EID: 67649234545     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2008.04.003     Document Type: Review

References (28)

1. Janeway C.A.J. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol (1989) 54
2. Kanzler H., Barrat F.J., Hessel E.M., and Coffman R.L. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 13 (2007) 552-559
3. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science 282 (1998) 2085-2088
4. Medzhitov R., Preston-Hurlburt P., and Janeway C.A.J. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 388-394
5. Akira S., Satoshi U., and Osamu T. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
6. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immun 5 (2004) 987-995
7. Kawai T., and Akira S. Signaling to NF-kB by Toll-like receptors. Trends Mol Med 13 11 (2007) 462-469
8. O'Neill L.A.J. After the Toll rush. Science 303 (2004) 1481-1482
9. Mollen K.P., Anand R.J., Tsung A., Prince J.M., Levy R.M., and Billiar T.R. Emerging paradigm: Toll like receptor 4 sentinel for the detection of tissue damage. Schoc 26 5 (2006) 430-437
10. Funderburg N., Lederman M.M., Feng Z., Drage M.G., and Jadlowsky J. Harding,Aaron Weinberg C.V., Sieg S.F. Human-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. PNAS 104 47 (2007) 18631-18635
11. Banerjee A., and Gerondakis S. Coordinating TLR activated signaling pathways in cells of the immune system. Immunol Cell Biol 85 (2007) 420-424
12. Zaru R., Ronkina N., Gaeste M., Arthur J.S.C., and Watts C. The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nat Immun 8 11 (2007) 1227-1235
13. Xu D., Liu H., and Komai-Koma M. Direct and indirect role of Toll-like receptors in T cell mediated immunity. Cell Mol Immunol 1 4 (2004) 239-246
14. Baccala R., Hoebe K., Kono D.H., Beutler B., and Theofilopoulos A.N. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 13 (2007) 543-551
15. Pasare C., and Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 438 (2005) 364-368
16. Barr T.A., Brown S., Ryan G., Zhao J., and Gray D. TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur J Immunol 37 (2007) 3040-3053
17. Meyer-Bahlburg A., Khim S., and Rawlings D.J. B cell - intrinsic TLR signals amplify but are not required for humoral immunity. JEM 204 13 (2007) 3095-3101
18. Imler J., and Hoffman J.A. Toll receptors in innate immunity. Trends Cell Biol 11 (2001) 304-311
19. Kawai T., and Akira S. SnapShot: Pattern recognition receptors. Cell 129 (2007) 1024-1025
20. Salaun B., Romero P., and Lebecque S. Toll-like receptors' two-edged sword: when immunity meets apoptosis. Eur J Immunol 37 (2007) 1-8
21. Lang T., and Mansell A. The negative regulation of Toll-like receptor and associated pathways. Immunol Cell Biol 85 (2007) 425-434
22. Duin D.V., Medzhitov R., and Shaw A.C. Triggering TLR signaling in vaccination. Trends Immunol 27 1 (2006) 49-55
23. Tse K., and Horner A.A. Update on toll-like receptor-directed therapies for human disease. Ann Rheum Dis 66 (2007) 77-80
24. Racila D.M., and Kline J.N. Perspectives in asthma: Molecular use of microbial products in asthma prevention and treatment. J Allergy Clin Immunol 116 6 (2005) 1202-1205
25. Sweeney S.E., and Firestein G.S. Primer: signal transduction in rheumatic disease a clinician's guide. Nat Clin Pract Rheumatol 3 11 (2007) 651-660
26. Sacre S.M., Drexler S.K., Andreakos E., Feldmann F., Brennan F.M., and Foxwell B.M.J. Could toll-like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissue. Ann Rheum Dis 66 Suppl. III (2007) 81-86
27. Ermann J., and Bermas B.L. The biology behind the new therapies for SLE. Int J Clin Pract 61 12 (2007) 2113-2119
28. Land W.G. Innate alloimmunity: History and current knowledge. Exp Clin Transplant 5 1 (2007) 575-584